Author:
Colmenares-Aguilar María,Lima Lucimey
Reference43 articles.
1. Anderson GM (2004) Peripheral and central neurochemical effects of the selective serotonin reuptake inhibitors (SSRIs) in humans and nonhuman primates: assessing bioeffect and mechanisms of action. Int J Develop Neurosci 22:397–404
2. Aune TM, McGrath KM, Sarr T, Bombara MP, Kelley KA (1993) Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine. J Immunol 151:1175–1183
3. Aune TM, Golden HW, McGrath KM (1994) Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. J Immunol 153:489–498
4. Brechard S, Salsmann A, Tschirhart J (2009) OAG induces an additional PKC-, PI3K-, and Rac2-mediated signaling pathway up-regulating NOX2 activity, independently of Ca2+ entry. J Leuk Bio 85:638–647
5. Cedeño N, Urbina M, Obregón F, Lima L (2005) Characterization of serotonin transporter in blood lymphocytes of rats. Modulation by in vivo administration of mitogens. J Neuroim 159:31–40